Electrosurgical generator with adaptive power control

- Covidien AG

An electrosurgical generator has an output power control system that causes the impedance of tissue to rise and fall in a cyclic pattern until the tissue is desiccated. The advantage of the power control system is that thermal spread and charring are reduced. In addition, the power control system offers improved performance for electrosurgical vessel sealing and tissue welding. The output power is applied cyclically by a control system with tissue impedance feedback. The impedance of the tissue follows the cyclic pattern of the output power several times, depending on the state of the tissue, until the tissue becomes fully desiccated. High power is applied to cause the tissue to reach a high impedance, and then the power is reduced to allow the impedance to fall. Thermal energy is allowed to dissipate during the low power cycle. The control system is adaptive to tissue in the sense that output power is modulated in response to the impedance of the tissue.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

This application is a Continuation of U.S. application Ser. No. 08/838,548, filed on Apr. 9, 1997, now U.S. Pat. No. 6,033,399, the contents of which are incorporated herein by reference.

BACKGROUND

1. Field of the Invention

The present invention relates to an electrosurgical generator with an adaptive power control, and more particularly to an eleosurgical generator that controls the output power in a manner that causes impedance of tissue to rise and fall cyclically until the tissue is completely desiccated.

2. Background of the Disclosure

Electrosurgical generators are used by surgeons to cut and coagulate tissue of a patient. High frequency electrical power is produced by the electrosurgical generator and applied to the surgical site by an electrosurgical tool. Monopolar and bipolar configurations are common in electrosurgical procedures.

Electrosurgical generators are typically comprised of power supply circuits, front panel interface circuits, and RF output stage circuits. Many electrical designs for electrosurgical generators are known in the field. In certain electrosurgical generator designs, the RF output stage can be adjusted to control the RMS output power. The methods of controlling the RF output stage may comprise changing the duty cycle, or changing the amplitude of the driving signal to the RF output stage. The method of controlling the RF output stage is described herein as changing an input to the RF output stage.

Electrosurgical techniques have been used to seal small diameter blood vessels and vascular bundles. Another application of electrosurgical energy is tissue welding. In this application, two layers of tissue are grasped and clamped together while electrosurgical power is applied. The two layers are thereby welded together. Tissue welding is similar to vessel sealing, except that a vessel or duct is not necessarily sealed in this process. For example, tissue welding may be used instead of staples for surgical anastomosis. Electrosurgical power has a desiccating effect on tissue during tissue welding or vessel sealing. As used herein, the term “electrosurgical desiccation” is meant to encompass any tissue desiccation procedure, including standard electrosurgical coagulation, desiccation, vessel sealing, and tissue welding.

One of the problems associated with electrosurgical desiccation is undesirable tissue damage due to thermal effects. The tissue at the operative site is heated by the electrosurgical current. Healthy tissue adjacent to the operative site can become thermally damaged if too much heat is allowed to build up at the operative site. The heat may conduct to the adjacent tissue and cause a large region of tissue necrosis. This is known as thermal spread. The problem of thermal spread becomes important when electrosurgical tools are used in close proximity to delicate anatomical structures. Therefore, an electrosurgical generator that reduced the possibility of thermal spread would offer a better opportunity for a successful surgical outcome.

Another problem that is associated with electrosurgical desiccation is a buildup of eschar on the surgical tool. Eschar is a deposit on an electrosurgical tool that is created from tissue that is desiccated and then charred by heat. The surgical tools win often lose effectiveness when they are coated with eschar. The buildup of eschar could be reduced when less heat is developed at the operative site.

Practitioners have known that a measurement of electrical impedance of tissue is a good indication of the state of desiccation of the tissue. Several commercially available electrosurgical generators can automatically terminate output power based on a measurement of impedance. Several methods for determining the optimal point of desiccation are known in the field. One method sets a threshold impedance, and terminates power once the measured impedance of the tissue crosses the threshold. Another method terminates power based on dynamic variations in the impedance.

A discussion of the dynamic variations of impedance of tissue can be found in the article, Vallfors and Bergdahl “Automatically Controlled Bipolar Electrocoagulation,” Neurosurgical Review, 7:2-3, pp. 187-190, 1984. FIG. 2 in the Vallfors article shows impedance as a function of time during heating of tissue. Valfors reports that the impedance value of tissue proved to be close to minimal at the moment of coagulation. Based on this observation, Vallfors suggests a micro-computer technique for monitoring the minimum impedance and subsequently terminating output power to avoid charring the tissue.

A second article by Bergdahl and Vallfors, “Studies on Coagulation and the Development of an Automatic Computerized Bipolar Coagulator,” Journal of Neurosurgery, 75:1, 148-151, July 1991, discusses the impedance behavior of tissue and its application to electrosurgical vessel sealing. The Bergdahl article reported that the impedance had a minimum value at the moment of coagulation. The Bergdahl article also reported that it was not possible to coagulate safely arteries with a diameter larger than 2 to 2.5 millimeters. The present invention helps to overcome this limitation by enabling electrosurgical vessel sealing of larger diameter vessels.

U.S. Pat. No. 5,540,684 discloses a method and apparatus for electrosurgically treating tissue in a manner similar to the disclosures of Vallfors and Bergdahl. The '684 patent addresses the problem associated with turning off the RF output automatically after the tissue impedance has reached a minimum value. A storage device records maximum and minimum impedance values, and an algorithm computes an optimal time for terminating output power.

U.S. Pat. No. 4,191,188 discloses a variable crest factor electrosurgical generator. The crest factor is disclosed to be associated with the coagulation effectiveness of the electrosurgical waveform.

U.S. Pat. No. 5,472,443 discloses the variation of tissue impedance with temperature. The impedance of tissue is shown to fall, and then subsequently rise as the temperature is increased. The '443 patent shows a relatively lower temperature region (Region A in FIG. 2) where salts, contained within the body fluids, are believed to dissociate, thereby decreasing the electrical impedance. The relatively next higher temperature region (Region B) is where the water in the tissues boils away, causing the impedance to rise. The relatively highest region (Region C) is where the tissue becomes charred, resulting in a slight lowering of impedance.

It would be desirable to have an electrosurgical generator that produced a clinically effective output and, in addition, reduced the amount of heat and thermal spread at the operative site. It would also be desirable to have an electrosurgical generator that produced a better quality seal for vessel sealing and tissue welding operations. It would also be desirable to have an electrosurgical generator that desiccated tissue by applying a minimal amount of electrosurgical energy.

SUMMARY OF THE INVENTION

The present invention relates to an electrosurgical generator having an improved output power controller for increasing the quality and reliability of electrosurgically sealing vessels, sealing ducts, welding and desiccating tissue. In particular, the output power is controlled in a manner that causes impedance of tissue to rise and fall repeatedly until the tissue is completely desiccated. The output power and the tissue impedance are both part of a control system wherein the output power is cycled to thereby cause a cycling of the tissue impedance. A basis for this invention is an experimental observation that the electrical impedance of tissue will usually rise when electrosurgical power is applied, and the electrical impedance of tissue will usually fall when the electrosurgical power is reduced or terminated. Presently available electrosurgical generators will monitor the rising impedance of tissue as power is applied. However, the applicant is the first to design an electrosurgical generator with a power control system that actively cause the impedance of the tissue to rise and fall repeatedly until the tissue is desiccated, and thereby achieve beneficial surgical effects.

The application of electrosurgical power is known to cause the impedance of tissue to fall to a local minimum and then rise monotonically thereafter. If the electrosurgical power is applied for too long, the tissue may char and stick to the electrode. Whereas prior designs terminated output power after the first local minimum in the impedance measurement, the present invention actively causes several local impedance minima to occur. Power can be terminated in the present invention based on an impedance limit, a time limit, or based on the responsiveness of the tissue to changes in output power from the generator.

An advantage of the present invention is that it can coagulate tissue with a reduced level of tissue charring. Another benefit of the present invention is that it has improved tissue sealing characteristics. Yet another benefit of the present invention is that it reduces thermal spread and thereby reduces damage to adjacent tissue. Yet another advantage of the present invention is that it reduces the tendency for eschar buildup on the electrosurgical tool. Yet another advantage of the present invention is that large vessels and ducts can be electrosurgically sealed.

It is thought that impedance of tissue can rise and fall depending on several factors, including output power, output voltage, output current, temperature, and pressure on the tissue exerted by surgical graspers. The present invention addresses changes in impedance of tissue that can be attributed to electrosurgical power application, wherein the power can be adjusted by changing the output voltage or the output current. The present invention causes the tissue impedance to rise and fall repeatedly until the tissue is completely desiccated. The present invention adjusts the output power in a manner that is based on feedback from a tissue impedance measurement.

According to the present invention, the impedance of the tissue rises and falls in response to relatively low frequency cycling of the electrosurgical power. The electrosurgical power is raised and lowered (also referenced herein as “cycled”) at a relatively low frequency, and the impedance of the tissue is thereby caused to rise and fall at approximately the same frequency until the tissue becomes desiccated. The manner in which the electrosurgical power is raised and lowered may be accomplished in several ways which incorporate well known principles of control system design.

The frequency of power cycling in the present invention is different from the RF modulation frequency of the electrosurgical waveforms, which are typically in the range of one hundred kilohertz to one megahertz. The frequency of power cycling of the present invention is also different from the duty cycle of generators that causes a coagulation effect on tissue, which is typically in the frequency range above one thousand hertz. The frequency range of power cycling in the present invention is typically between one and twenty hertz. Both the RF modulation and the duty cycling of present electrosurgical generators may occur simultaneously with the power cycling of the present invention.

The frequency at which the electrosurgical power is raised and lowered (i.e. cycled or modulated) should not be too high, otherwise the impedance of the tissue will not be able to rise and fall in response with an amplitude that will produce additional benefits. Similarly, the frequency should not be too low, otherwise the beneficial aspects of the invention will not become apparent because the tissue will desiccate without any appreciable modulation. The range of effective frequencies of the present invention has been called “thermal bandwidth.”

The behavior of the tissue impedance is possibly related to the thermal time constant of the tissue. There are additional factors that affect the tissue impedance, including the water content in the tissue and steam. After the tissue is desiccated, which is indicated by a high measured impedance, further application of electrosurgical power will cause undesirable charring. Thus, it is preferred to have impedance monitoring to determine the appropriate time for terminating the electrosurgical power. Impedance monitoring is also preferred so that the modulation frequency of the electrosurgical power can be automatically adjusted and kept within the thermal bandwidth.

It is theorized by the inventor that thermal spread during electrosurgical desiccation is created in at least three ways. The first is through direct thermal conduction away from the weld site. The second is from hot steam exiting the weld site. This mechanism is perhaps far more significant than the first, because of the steam's high mobility. The third mechanism is the lateral spread of current away from the weld site. It is theorized that the third mechanism is due to steam creating a high impedance pathway between the jaws, which forces a larger portion of the current to flow laterally. The present invention controls the output power in a manner that reduces thermal spread.

The present invention is relevant to all electrosurgical generators. It has been found to be particularly relevant to bipolar electrosurgical applications, as well as to elecosurgical tissue welding and vessel sealing. Skilled practitioners will recognize the value of the invention wherever tissue desiccation is accomplished by electrosurgical methods.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a block diagram representation of an adaptive oscillatory power curve according to the present invention.

FIG. 2(a) is a sample of experimental data for a standard vessel sealing operation, showing output power as function of time.

FIG. 2(b) is a sample of experimental data for a standard vessel sealing operation, showing load impedance as a function of time.

FIG. 2(c) is a sample of experimental data for a standard vessel sealing operation, showing output current as a function of time.

FIG. 2(d) is a sample of experimental data for a standard vessel sealing operation, showing output voltage as a function of time.

FIG. 3(a) is a sample of experimental data for an adaptive power control generator, showing output power as fiction of time.

FIG. 3(b) is a sample of experimental data for an adaptive power control generator, showing load impedance as a function of time.

FIG. 3(c) is a sample of experimental data for an adaptive power control generator, showing output current as a function of time.

FIG. 3(d) is a sample of experimental data for an adaptive power control generator, showing output voltage as a function of time.

FIG. 4(a) is a representation of a power curve for a standard electrosurgical generator.

FIG. 4(b) is a representation of an adaptive oscillatory power curve.

DETAILED DESCRIPTION OF THE INVENTION

The present invention discloses an adaptive, oscillatory power curve which is able to reduce thermal spread in each of these areas by applying power in a cyclical fashion, rather than continuously. During the periods of reduced power application, thermal energy is allowed to dissipate which reduces direct thermal conduction. Also, the steam exits the weld site in smaller bursts, which produces less thermal damage than one large burst. Finally, the impedance between the jaws of the electrosurgical instrument is kept low, which allows current to flow more directly between the jaws.

Charring is also reduced. High voltages contribute to tissue charring, which is why it is preferable to limit the output voltage of the electrosurgical general to 120 volts, and to periodically reduce it to a lower value during power cycling. A relatively low voltage is also important because it prevents electrical sparks, or arcs, from passing through the tissue and burning small holes in the newly sealed, or welded, tissue.

The transparency, or clarity, at the weld site has been identified as an indicator of successful seal completion. It also gives the surgeon visual feedback as to whether the seal is a success. Preliminary findings indicate that this method may also increase weld site transparency. The reason for this is unknown, but it seems reasonable that reduced charring will allow the weld site to remain more transparent.

Referring to FIG. 1, a block diagram of an adaptive oscillatory power control system 10 is shown. The line designated by the letter A represents the command input signal to the control system 10. The command input signal A is preferably a periodic function, and in stain embodiments the period may vary depending on the dynamics of the tissue. The signal A is representative of the desired tissue impedance. A measurement of tissue impedance is represented by line B. A summing block 11 compares the command input signal A with the measured tissue impedance B to produce a difference signal C. The summing block 11 may be comprised of an electrical comparator circuit as is commonly known to control systems engineers.

The difference signal C may be input to a controller 12 that generates a control signal D. The control signal D adjusts or terminates the output power of the electrosurgical generator by changing the state of the RF. Output Stage 13. The controller 12 may be comprised of an algorithm in a microprocessor that determines the conditions for power termination based on the amplitude of the control signal. Alternatively and equivalently, the controller 12 may be connected directly to the measured tissue impedance B to terminate power based on the amplitude of the measured tissue impedance B. The controller 12 may be comprised of any combination of proportional integral, and derivative control laws that are known to control system engineers. Other types of control laws, such as “bang-bang ” control laws, are effective equivalents.

In one embodiment, the command input signal A has a cyclic pattern, for example a sine wave or a square wave. The cyclic nature of the command input signal A causes the control system 10 to regulate the output power in a cyclic manner to achieve beneficial surgical effects. The controller 12 monitors the difference signal C to determine the response of the output power E. In one embodiment, when the difference signal C is large, and the impedance measurement B is above threshold, then the controller 12 terminates the output power E.

The control signal D is preferably connected to an R.F. Output Stage 13. The control signal D preferably changes a driving voltage in the R.F. output stage to thereby change the RMS output power from the electrosurgical generator, shown as line E in FIG. 1. Alternatively and equivalently, the control signal D may change the duty cycle of the R.F. Output Stage 13 thereby effectively changing the RMS output power. Other means of changing RMS output power from an R.F. Output Stage, such as changing current, are known to electrical engineers.

The generator R.F. Output Stage 13 causes the electrosurgical generator to output a power level E to the tissue 14 of the patient. The tissue 14 becomes desiccated, thereby changing the electrical impedance, shown by F in FIG. 1. The electrical impedance F of the tissue is measured by an impedance measurement circuit 15 and reported as the measured tissue impedance B. The impedance measurement circuit 15 may be any form of electrical circuit that measures, or estimates, electrical impedance. The measured tissue impedance B is preferably an electrical signal that is proportional to the actual tissue impedance F.

Electrical engineers will recognize that output power from an electrosurgical generator can be adjusted in several ways. For example, the amplitude of the output power can be adjusted. In another example, the output power can be adjusted by changing the duty cycle or the crest factor. The change or adjustment in output power, as used herein is meant to refer any change or adjustment in the root mean square (RMS) value of the output power of the electrosurgical generator.

In operation, the control system 10 is designed to cycle the tissue impedance F for preferably several cycles in order to achieve beneficial effects. Thus, the command input signal A is a cyclically varying signal such as a sine wave. An example of cyclical impedance behavior of tissue is shown in FIG. 3(b). The generator output power that caused the cyclical impedance behavior is shown in FIG. 3(a). The cyclical behavior of the present invention can be contrasted with a standard electrosurgical generator wherein the output power is shown in FIG. 2(a) and the tissue impedance is shown in 2(b).

The present invention discloses an adaptive, oscillatory power curve which is able to reduce thermal spread in each of these areas by applying power in a cyclical fashion, rather than continuously. During the periods of reduced power application, thermal energy is allowed to dissipate which reduces direct thermal conduction. Also, the steam exits the weld site in smaller bursts, which produces less thermal damage than one large burst. Finally, the impedance between the jaws of the electrosurgical instrument is kept low, which allows current to flow more directly between the jaws.

Charring is thought to be reduced by the present invention. High voltages contribute to tissue charring, which is why it is preferable to limit the output voltage of the electrosurgical generator to 120 volts, and to periodically reduce it to a lower value during power cycling. A relatively low voltage is also important because it prevents electrical sparks, or arcs, from passing through the tissue and burning small holes in the newly sealed, or welded, tissue.

The transparency, or clarity, at the weld site has been identified as an indicator of successful seal completion. It also gives the surgeon visual feedback as to whether the seal is a success. Preliminary findings indicate that this method may also increase weld site transparency. The reason for this is unknown, but it seems reasonable that reduced charring will allow the weld site to remain more transparent.

A plot of output power vs. load impedance is called a “power curve.” A representation of a standard power curve is shown in FIG. 4(a). At low impedance, the output is typically current limited, and this is shown as the “constant current” line segment on FIG. 4(a). At midranges of impedance, the electrosurgical generator has a power control system that maintains the output power at a constant level by adjusting the output voltage, as shown by the “constant power” line segment on FIG. 4(a). Eventually, the load impedance becomes large, and the output power cannot be maintained without applying unacceptably high output voltages. Thus, a voltage limit is reached, and the output power drops off because the output current is falling and the output voltage is at a limit. The drop in output power is shown as the “constant voltage” line segment in FIG. 4(a).

The present invention is related to an electrosurgical generator having an adaptive oscillatory power curve as shown in FIG. 4(b). The adaptive oscillatory power curve is produced by a power control system in the electrosurgical generator. The design details of the control system can be implemented in several ways which are well known to control system engineers.

The first part of the adaptive oscillatory power curve, shown at the line segment I in FIG. 4(b), is similar to the standard power curve, wherein the generator applies high current into a low impedance load until a maximum power limit, shown as A, is reached. In the next “leg” of the power curve, shown by line segment B, output current begins to fall, and output voltage begins to rise as the generator adjusts the output voltage to maintain constant output power at the level marked by A. The generator then begins looking for signs to indicate the onset of boiling in the tissue. Such signs include a very rapid rise in impedance, or a high value of voltage, such as 120 volts. The local maximum of the impedance curve is shown by letter K in FIG. 4(b). The dotted line, marked C and labeled V=120 V, shows the possible output power if the generator were to maintain a voltage limit of 120 volts, which is a preferred voltage limit. Rather than follow the V=120 V line, a controller in the generator drops the output power. This can be accomplished, in one embodiment, by dropping the output voltage limit to between zero and 70 volts, and preferably 50 volts, as shown in line segment D. In another embodiment of the control system, the output power can be reduced by other combinations of output current reduction and/or output voltage reduction.

As a consequence of the lower voltage limit, the output power drops to the level indicated by H in FIG. 4(b). In certain embodiments, H may be zero watts. At this lower output power, desiccation stops and the tissue impedance starts to fall. A preferred lower voltage limit of 50 volts may be used as shown by dotted line E and marked “V=50 volts”. Once the impedance has reached a local minimum, shown by J, or after a set period of time, the power control system raises the output power back to level A, which corresponds to an output voltage limit of 120 volts in the preferred embodiment. Thus, the output power rises back to level A, and the impedance rises again, until the onset of boiling or an impedance threshold is reached. The cyclical portion of the power curve incorporating line segments B, D, and E is an important part of this invention and will continue until the tissue is desiccated. When the tissue is desiccated, the power will terminate as shown when impedance reaches point L. In certain embodiments, point L will be substantially the same as point K.

The behavior shown in FIG. 4(b) can be observed in FIGS. 3(a), 3(b), 3(c) and 3(d). Power oscillations between 120 watts and 20 watts in FIG. 3(a) correspond to cyclical movement between power level A and power level H in FIG. 4(b). Impedance oscillations in FIG. 3(b) correspond to cyclical movement between impedance level K and impedance level J in FIG. 4(b). It will be understood by control systems engineers that FIG. 4(b) is highly idealized, and the cyclical behavior may not always reach exactly the same local maxima and minima. This can be observed in FIG. 3(a), where the local maxima of the power curve may not always reach 120 volts.

It is theorized by the inventor that the following phenomena occur. The initial high output power initiates boiling in the tissues. The subsequent low output power is insufficient to maintain boiling, and hence boiling in the tissue stops. After boiling stops, if the tissue is not completely desiccated then the impedance will fall to a lower value. Next, the low impedance allows output power to increase, which re-heats the tissue to the point of boiling. The voltage is also pulled higher during the process, and remains so until the power curve can sense the onset of boiling, and lower the voltage, preferably back to 50 volts. The process continues until the tissue is fully desiccated. An oscillation is one cycle of high output power followed by low output power.

FIGS. 2(a) through 2(d) show experimental results on tissue samples using a standard power curve. FIGS. 3(a) through 3(d) show experimental results using an adaptive oscillatory power curve. The general nature of the invention can be seen by comparing FIG. 2(a) with FIG. 3(a). FIG. 2(a) shows a 100 watt electrosurgical output that is applied continuously to tissue. As the tissue desiccates, the impedance of the tissue rises and the output power in FIG. 2(a) is seen to fall off below 20 watts. In contrast, FIG. 3(a) shows an oscillating output power that varies from approximately 100 watts to approximately 20 watts. The effects on tissue impedance can be seen by comparing FIG. 2(b) with FIG. 3(b). The tissue impedance resulting from the standard power curve is shown to continuously increase in FIG. 2(b), perhaps after an initial drop. The tissue impedance resulting from the adaptive oscillatory power curve is shown to oscillate in FIG. 3(b) and thus has several local minima.

Output voltage and output current show a cyclic behavior in the adaptive oscillatory power curve. The cyclic behavior is absent in the standard power curve. FIGS. 2(c) and 3(c) can be compared to show the difference in output current between the standard power curve and the adaptive oscillatory power curve. In each case the maximum output current rises above 2 amps RMS. FIGS. 2(d) and 3(d) can be compared to show the difference in output voltage between the standard power curve and the adaptive oscillatory power curve. A voltage limit, preferably in each case 120 volts, prevents arcing that might leave pinholes in the tissue seal.

In one embodiment of the adaptive oscillatory power curve, the generator temporarily lowers the output voltage limit to 50 volts whenever the output voltage reaches 120 volts. This causes a reduction in output power, and if the tissue is not completely desiccated, a corresponding significant reduction in tissue impedance. After the reduction in tissue impedance, the output voltage limit is reset to 120 volts, allowing a rise in output power. This reduction and subsequent rise in output power constitutes a cycle.

Designers of electrosurgical generators have found that impedance is a good indicator of the desiccation state of the tissue. However, skilled artisans will recognize that it may not be necessary to compute an exact value for impedance. An electrical measurement that is proportional to the tissue impedance can be used as a functional equivalent. In one embodiment, the control system can properly create the adaptive oscillatory power curve based on measurements of time, and output voltage.

Table 1 shows a comparison between two sets of tests which compare a standard power curve with an adaptive oscillatory power curve. Test 1 indicates use of the standard power curve, while Test 2 indicates the use of the adaptive oscillatory power curve. Size indicates the vessel diameter in millimeters, burst pressures are measured in p.s.i., sticking, charring, and clarity are subjective measures ranked from 0 to 3, (where 0 represents a low value for sticking and charring, and 0 represents a poor value for clarity), and ts indicates thermal spread, measured in millimeters.

TABLE 1 Comparison of Standard Power Curve with Adaptive Power Curve Test # samples size bp stick charring clarity ts 1 (mean) 19 2.57 17.26 .63 1.11 1.89 2.11 1 (SD) 1.35 1.04 .76 .81 1.29 .74 1 (min) 1 12.96 1 (max) 6 17.50 2 (mean) 20 2.55 17.39 .80 .60 1.95 1.65 2 (SD) 1.36 .44 1.06 .60 1.36 .81 2 (min) 1 15.52 2 (max) 5 17.50

Table 1 illustrates that the adaptive oscillatory power curve (Test 2) has several advantages over the standard power curve (Test 1). Most notable is the lower amount of thermal spread: a mean value of 2. 1 mm for the standard power curve, and 1.65 mm for the adaptive oscillatory power curve. The subjective measures for sticking, charring and clarity of the weld show that the adaptive oscillatory power curve offer improvements over the standard power curve.

In general, the invention is an electrosurgical generator for treating tissue, wherein the electrosurgical generator comprises a circuit for generating a measurement of the load impedance, and an output power controller having means for inducing multiple oscillations of the load impedance in response to the measurement. The load impedance refers to the impedance of the tissue being treated by the electrosurgical generator. The circuit for generating a measurement of the load impedance can be analog or digital, and typically requires an output voltage sensor and an output current sensor. The output voltage is divided by the output current to compute a measurement of load impedance.

The means for inducing multiple oscillations of the load impedance preferably comprises a control system which can selectively control the output voltage to cause appropriate oscillations of the output power. In many electrosurgical generators, an output power control circuit has an adjustable voltage supply connected to the primary side of an isolation transformer. The secondary winding of the transformer is connected to an output resonant circuit. The voltage supply has an adjuster for changing the voltage to the transformer, and thereby changing the output voltage of the electrosurgical generator. A digital signal may be used to control the voltage supply.

The means for inducing multiple oscillations preferably comprise a feedback control system, where the feedback is a measurement of the load impedance. The control system preferably includes an algorithm in a microprocessor. The algorithm in the microprocessor can monitor the load impedance and determine how the load impedance is responding to a change in the output power.

In the preferred embodiment, the control system sets an output voltage limit of 120 volts RMS, and then controls the output power to a user desired setting, for example 100 watts. When the impedance is relatively low, a high current will combine with an output voltage of less than 120 volts to yield the desired power of 100 watts. As the impedance rises, the output current will fall, and the output voltage will be increased by the circuit to maintain the desired output power. When the voltage limit of 120 volts is reached, the control system will automatically lower the output voltage to a low value, preferably 50 volts. This effectively lowers the output power. If the tissue is not completely desiccated, the lower output power will cause the impedance to drop significantly. Once a local impedance minimum is detected, or after a set period of time, the output voltage limit is reset to 120 volts by the control system, and the cycle repeats. It has been found through experimentation that the oscillations of the load impedance will occur in the frequency range of one to twenty hertz, and this range has been referred to herein as the thermal bandwidth. In one embodiment, the control system terminates the output power after a set period of time which was three seconds. Alternatively, the control system can terminate power when the impedance reaches a threshold of 2000 ohms. Another alternative is to terminate output power when the measurement of impedance indicates that the impedance does not substantially fall in response to a drop in the output power.

The present invention is applicable to any form of electrosurgical coagulation. The benefits of the present invention, including reduced thermal spread, less eschar buildup, and improved desiccation, can be applied to both monopolar and bipolar electrosurgical generator outputs. While a particular preferred embodiment has been illustrated and described, the scope of protection sought is in the claims that follow.

Claims

1. An electrosurgical generator for applying output power to tissue to desiccate tissue, the electrosurgical generator comprising:

a controller for cycling the output power to cause a cycling of the tissue impedance; and
a tissue impedance measurement circuit coupled to said controller for measuring impedance of the tissue;
wherein the controller cycles the output power by applying a predetermined amount of output power to said tissue, lowering the output power upon an output voltage reaching a predetermined maximum, re-applying the predetermined amount of output power to said tissue of a measured tissue impedance does not indicate desiccation of the tissue, and terminating output power when the measured tissue impedance exceeds a predetermined value, the predetermined value corresponding to a desiccated condition of tissue.

2. The generator of claim 1, wherein the controller changes the output voltage to cycle the output power.

3. The generator of claim 1, wherein the controller changes the output current to cycle the output power.

4. The generator of claim 1, wherein the output voltage is cycled by lowering the output voltage once it reaches a predetermined maximum and raising the output voltage if the reduction in measured tissue impedance does not indicate desiccation of the tissue.

5. The generator of claim 1, wherein the output power is cycled at a frequency that is between 1 and 20 Hz.

6. The generator of claim 1, wherein the output voltage does not exceed 120 volts.

7. The generator of claim 1, further comprising a comparator wherein the measured tissue impedance value is compared to a first signal representative of a desired tissue impedance value by the comparator and a difference signal is produced.

8. The generator of claim 7, wherein the difference signal is input to the controller which generates a signal to adjust the power.

9. The generator of claim 7, wherein the first signal has a cyclic pattern.

10. The generator of claim 9, wherein the first signal is a sine wave.

11. An electrosurgical generator for treating tissue by applying energy comprising:

a desiccation detector for measuring a degree of desiccation of tissue; and
a controller for minimizing the burning of tissue comprising power control circuitry for repeatedly increasing and decreasing output power to the tissue to be treated, the power control circuitry coupled to the desiccation detector and operating to adjust the output power in response to the degree of desiccation of the tissue by applying a predetermined amount of output power to said tissue, lowering the output power upon an output voltage reaching a predetermined maximum, and re-applying the predetermined amount of output power to said tissue if said desiccation detector does not indicate desiccation of the tissue.

12. The generator of claim 11, wherein the output power is terminated by said controller upon detection of desiccated tissue.

13. The generator of claim 12, wherein the desiccation detector further comprises impedance measuring circuitry, wherein the degree of desiccation of the tissue is determined by the impedance of the tissue measured by the impedance measuring circuitry.

14. The generator of claim 13, wherein the circuitry adjusts the output power by adjusting the output voltage within a predetermined voltage range.

15. The generator of claim 11, wherein the output power is repeatedly increased and decreased by the circuitry at a frequency between 1 and 20 Hz.

16. A method for applying energy to tissue to treat tissue, the method including supplying a generator having a power control system to produce an adaptive oscillatory power curve to minimize the heating effect on tissue, the method comprising:

a) applying a high current into a low impedance load until a maximum power is reached;
b) adjusting the output voltage to maintain constant output power as impedance increases as tissue begins to desiccate;
c) dropping the output power in response to a rapid rise in tissue impedance indicating the boiling of tissue;
d) allowing the tissue impedance to fall to a predetermined minimum value and then raising the output power to cause an increase in tissue impedance;
e) repeating steps b and c until impedance reaches a maximum value.

17. A method for applying energy to tissue to treat tissue, the method including supplying a generator having a power control system to produce an adaptive oscillatory power curve to minimize the heating effect on tissue, the method comprising:

a) applying a high current into a low impedance load until a maximum power is reached;
b) adjusting the output voltage to maintain constant output power as impedance increases as tissue begins to desiccate;
c) dropping the output power if the output voltage exceeds a maximum value;
d) raising the output power after a predetermined period of time to cause an increase in tissue impedance; and
e) repeating steps b and c until impedance reaches a maximum value.

18. A method for applying energy to tissue to treat the tissue, comprising steps of:

providing an electrosurgical generator;
coupling an output of the generator to tissue to be treated; and
coupling electrosurgical energy from the generator into the tissue in an oscillatory manner until an impedance of the tissue rises to a value that indicates that the tissue is desiccated, wherein the electrosurgical energy is coupled into the tissue with an oscillatory frequency that lies within a thermal bandwidth of the tissue.

19. A method as in claim 18, wherein the frequency is within a range of about one Hertz to about 20 Hertz.

20. A method of applying energy to tissue to treat the tissue, the method including supplying a generator having a power control system to produce an adaptive oscillatory power curve to minimize the heating effect on tissue, the method comprising the steps of:

applying a high current into a low impedance load until a maximum power is reached;
adjusting the output voltage to maintain constant output power as impedance increases as tissue begins to desiccate;
dropping the output power in response to a rapid rise in tissue impedance indicating the boiling of tissue;
allowing the tissue to cool until the tissue impedance reaches a predetermined minimum value and then raising the output power to cause an increase in tissue impedance; and
repeating the adjusting and dropping steps until the tissue impedance reaches a maximum value.

21. A method of applying energy to tissue to treat tissue, the method comprising the steps of:

supplying a generator having a power control system to produce an adaptive oscillatory power curve to minimize the heating effect on tissue;
coupling electrosurgical energy from the generator into the tissue in an oscillatory manner until an impedance of the tissue rises to a value that indicates that the tissue is desiccated;
adjusting an output voltage to apply output power to the tissue in a cyclical fashion such that there are periods of increased power application and periods of reduced power application; and
allowing thermal energy to dissipate during the periods of reduced power application.

22. The method of claim 21 wherein the electrosurgical energy is coupled into the tissue with an oscillatory frequency that lies within a thermal bandwidth of the tissue.

23. The method of claim 22 wherein the frequency is within a range of about one Hertz to about 20 Hertz.

24. The method of claim 21 wherein the output voltage of the generator is limited to 120 volts to further minimize the heating effect on the tissue.

Referenced Cited
U.S. Patent Documents
1787709 January 1931 Wappler
1813902 July 1931 Bovie
1841968 January 1932 Lowry
1863118 June 1932 Liebel
1945867 February 1934 Rawls
2827056 March 1958 Degelman
2849611 August 1958 Adams
2982881 May 1961 Reich
3058470 October 1962 Seeliger et al.
3089496 May 1963 Degelman
3163165 December 1964 Islikawa
3252052 May 1966 Nash
3391351 July 1968 Trent
3402326 September 1968 Guasco et al.
3413480 November 1968 Biard et al.
3436563 April 1969 Regitz
3439253 April 1969 Piteo
3439680 April 1969 Thomas, Jr.
3461874 August 1969 Martinez
3471770 October 1969 Haire
3478744 November 1969 Leiter
3486115 December 1969 Anderson
3495584 February 1970 Schwalm
3513353 May 1970 Lansch
3514689 May 1970 Giannamore
3515943 June 1970 Warrington
3551786 December 1970 Van Gulik
3562623 February 1971 Farnsworth
3571644 March 1971 Jakoubovitch
3589363 June 1971 Banko
3595221 July 1971 Blackett
3601126 August 1971 Estes
3611053 October 1971 Rowell
3641422 February 1972 Farnsworth et al.
3662151 May 1972 Haffey
3675655 July 1972 Sittner
3683923 August 1972 Anderson
3693613 September 1972 Kelman
3697808 October 1972 Lee
3699967 October 1972 Anderson
3720896 March 1973 Bierlein
3743918 July 1973 Maitre
3766434 October 1973 Sherman
3768482 October 1973 Shaw
3783340 January 1974 Becker
3784842 January 1974 Kremer
3801766 April 1974 Morrison, Jr.
3801800 April 1974 Newton
3812858 May 1974 Oringer
3815015 June 1974 Swin et al.
3826263 July 1974 Cage et al.
3828768 August 1974 Douglas
3848600 November 1974 Patrick, Jr. et al.
3870047 March 1975 Gonser
3875945 April 1975 Friedman
3885569 May 1975 Judson
3897787 August 1975 Ikuno et al.
3897788 August 1975 Newton
3901216 August 1975 Felger
3905373 September 1975 Gonser
3913583 October 1975 Bross
3923063 December 1975 Andrews et al.
3933157 January 20, 1976 Bjurwill et al.
3946738 March 30, 1976 Newton et al.
3952748 April 27, 1976 Kaliher et al.
3963030 June 15, 1976 Newton
3964487 June 22, 1976 Judson
3971365 July 27, 1976 Smith
3980085 September 14, 1976 Ikuno
4005714 February 1, 1977 Hilebrandt
4024467 May 17, 1977 Andrews et al.
4041952 August 16, 1977 Morrison, Jr. et al.
4051855 October 4, 1977 Schneiderman
4063557 December 20, 1977 Wuchinich et al.
4074719 February 21, 1978 Semm
4092986 June 6, 1978 Schneiderman
4094320 June 13, 1978 Newton et al.
4102341 July 25, 1978 Ikuno et al.
4114623 September 19, 1978 Meinke et al.
4121590 October 24, 1978 Gonser
4123673 October 31, 1978 Gonser
4126137 November 21, 1978 Archibald
4145636 March 20, 1979 Doi
4188927 February 19, 1980 Harris
4191188 March 4, 1980 Belt et al.
4196734 April 8, 1980 Harris
4200104 April 29, 1980 Harris
4200105 April 29, 1980 Gosner
4209018 June 24, 1980 Meinke et al.
4231372 November 4, 1980 Newton
4232676 November 11, 1980 Herczog
4237887 December 9, 1980 Gosner
4237891 December 9, 1980 DuBose et al.
4281373 July 28, 1981 Mabille
4287557 September 1, 1981 Brehse
4303073 December 1, 1981 Archibald
4311154 January 19, 1982 Sterzer et al.
4314559 February 9, 1982 Allen
4321926 March 30, 1982 Roge
4334539 June 15, 1982 Childs et al.
4343308 August 10, 1982 Gross
4372315 February 8, 1983 Shapiro et al.
4376263 March 8, 1983 Pittroff et al.
4378801 April 5, 1983 Oosten
4384582 May 24, 1983 Watt
4397314 August 9, 1983 Vaguine
4407272 October 4, 1983 Yamaguchi
4411266 October 25, 1983 Cosman
4416276 November 22, 1983 Newton et al.
4416277 November 22, 1983 Newton et al.
4437464 March 20, 1984 Crow
4452546 June 5, 1984 Hiltebrandt et al.
4463759 August 7, 1984 Garito et al.
4470414 September 11, 1984 Imagawa et al.
4472661 September 18, 1984 Culver
4474179 October 2, 1984 Koch
4492231 January 8, 1985 Auth
4492832 January 8, 1985 Taylor
4494541 January 22, 1985 Archibald
4514619 April 30, 1985 Kugelman
4520818 June 4, 1985 Mickiewicz
4559943 December 24, 1985 Bowers
4565200 January 21, 1986 Cosman
4566454 January 28, 1986 Mehl et al.
4569345 February 11, 1986 Manes
4576177 March 18, 1986 Webster, Jr.
4582057 April 15, 1986 Auth et al.
4590934 May 27, 1986 Malis et al.
4608977 September 2, 1986 Brown
4630218 December 16, 1986 Hurley
4632109 December 30, 1986 Patterson
4644955 February 24, 1987 Mioduski
4646222 February 24, 1987 Okado et al.
4651264 March 17, 1987 Shiao-Chung Hu
4651280 March 17, 1987 Chang et al.
4657015 April 14, 1987 Irnich
4658815 April 21, 1987 Farin et al.
4658819 April 21, 1987 Harris et al.
4658820 April 21, 1987 Klicek
4662383 May 5, 1987 Sogawa et al.
4712559 December 15, 1987 Turner
4727874 March 1, 1988 Bowers et al.
4735204 April 5, 1988 Sussman et al.
4739759 April 26, 1988 Rexroth et al.
4741334 May 3, 1988 Irnich
4754757 July 5, 1988 Feucht
4805621 February 21, 1989 Heinze et al.
4818954 April 4, 1989 Flachenecker et al.
4827911 May 9, 1989 Broadwin et al.
4827927 May 9, 1989 Newton
4832024 May 23, 1989 Boussignac et al.
4848335 July 18, 1989 Manes
4848355 July 18, 1989 Nakamura et al.
4860745 August 29, 1989 Farin et al.
4862889 September 5, 1989 Feucht
4880719 November 14, 1989 Murofushi et al.
4890610 January 2, 1990 Kirwan et al.
4903696 February 27, 1990 Stasz et al.
4907589 March 13, 1990 Cosman
4922210 May 1, 1990 Flachenecker et al.
4931047 June 5, 1990 Broadwin et al.
4931717 June 5, 1990 Gray et al.
4938761 July 3, 1990 Ensslin
4942313 July 17, 1990 Kinzel
4961047 October 2, 1990 Carder
4961435 October 9, 1990 Kitagawa et al.
4966597 October 30, 1990 Cosman
RE33420 November 6, 1990 Sussman
4969885 November 13, 1990 Farin
4993430 February 19, 1991 Shimoyama et al.
4995877 February 26, 1991 Ams et al.
5015227 May 14, 1991 Broadwin et al.
5019176 May 28, 1991 Brandhorst, Jr.
5029588 July 9, 1991 Yock et al.
5087257 February 11, 1992 Farin
5103804 April 14, 1992 Abele et al.
5108389 April 28, 1992 Cosmescu
5108391 April 28, 1992 Flachenecker
5122137 June 16, 1992 Lennox
5133711 July 28, 1992 Hagen
5151102 September 29, 1992 Kamiyama et al.
5152762 October 6, 1992 McElhenney
5157603 October 20, 1992 Scheller et al.
5160334 November 3, 1992 Billings et al.
5162217 November 10, 1992 Hartman
5167658 December 1, 1992 Ensslin
5190517 March 2, 1993 Zieve et al.
5196008 March 23, 1993 Kuenecke
5196009 March 23, 1993 Kirwan, Jr.
5201900 April 13, 1993 Nardella
5207691 May 4, 1993 Nardella
5230623 July 27, 1993 Guthrie et al.
5233515 August 3, 1993 Cosman
5267994 December 7, 1993 Gentelia et al.
5267997 December 7, 1993 Farin
5281213 January 25, 1994 Milder et al.
5300068 April 5, 1994 Rosar et al.
5300070 April 5, 1994 Gentelia
5318563 June 7, 1994 Malis et al.
5323778 June 28, 1994 Kandarpa et al.
5324283 June 28, 1994 Heckele
5330518 July 19, 1994 Neilson et al.
5334193 August 2, 1994 Nardella
5341807 August 30, 1994 Nardella
5342356 August 30, 1994 Ellman
5342357 August 30, 1994 Nardella
5342409 August 30, 1994 Mullett
5348554 September 20, 1994 Imran et al.
5370645 December 6, 1994 Klicek et al.
5370672 December 6, 1994 Fowler et al.
5370675 December 6, 1994 Edwards et al.
5372596 December 13, 1994 Klicek et al.
5383874 January 24, 1995 Jackson
5383876 January 24, 1995 Nardella
5383917 January 24, 1995 Desai et al.
5385148 January 31, 1995 Lesh et al.
5396062 March 7, 1995 Eisentraut et al.
5400267 March 21, 1995 Denen et al.
5403311 April 4, 1995 Abele et al.
5403312 April 4, 1995 Yates et al.
5409000 April 25, 1995 Imran
5409006 April 25, 1995 Buchholtz et al.
5409485 April 25, 1995 Suda
5413573 May 9, 1995 Koivukangas
5417719 May 23, 1995 Hull et al.
5422567 June 6, 1995 Matsunaga
5423808 June 13, 1995 Edwards et al.
5423809 June 13, 1995 Klicek
5423810 June 13, 1995 Goble et al.
5430434 July 4, 1995 Lederer et al.
5432459 July 11, 1995 Thompson
5433739 July 18, 1995 Sluijter et al.
5434398 July 18, 1995 Goldberg
5436566 July 25, 1995 Thompson
5438302 August 1, 1995 Goble
5443463 August 22, 1995 Stern et al.
5445635 August 29, 1995 Denen
5451224 September 19, 1995 Goble et al.
5458597 October 17, 1995 Edwards et al.
5462521 October 31, 1995 Brucker et al.
5472441 December 5, 1995 Edwards et al.
5472443 December 5, 1995 Cordis et al.
5478303 December 26, 1995 Folry-Nolan et al.
5480399 January 2, 1996 Hebborn
5483952 January 16, 1996 Aranyi
5490850 February 13, 1996 Ellman et al.
5496312 March 5, 1996 Klicek
5496313 March 5, 1996 Gentelia et al.
5500012 March 19, 1996 Brucker et al.
5500616 March 19, 1996 Ochi
5514129 May 7, 1996 Smith
5520684 May 28, 1996 Imran
5531774 July 2, 1996 Schulman et al.
5534018 July 9, 1996 Wahlstrand et al.
5536267 July 16, 1996 Edwards et al.
5540681 July 30, 1996 Strul et al.
5540683 July 30, 1996 Ichikawa
5540684 July 30, 1996 Hassler, Jr.
5540724 July 30, 1996 Cox
5556396 September 17, 1996 Cohen et al.
5558671 September 24, 1996 Yates
5569242 October 29, 1996 Lax et al.
5571147 November 5, 1996 Sluijter et al.
5573533 November 12, 1996 Strul
5588432 December 31, 1996 Crowley
5594636 January 14, 1997 Schauder
5596466 January 21, 1997 Ochi
5599344 February 4, 1997 Paterson
5599345 February 4, 1997 Edwards et al.
5605150 February 25, 1997 Radons et al.
5613966 March 25, 1997 Makower et al.
5613996 March 25, 1997 Lindsay
5625370 April 29, 1997 D'Hont
5626575 May 6, 1997 Crenner
5628745 May 13, 1997 Bek
5643330 July 1, 1997 Holsheimer et al.
5647869 July 15, 1997 Goble et al.
5647871 July 15, 1997 Levine et al.
5651780 July 29, 1997 Jackson et al.
5658322 August 19, 1997 Fleming
5660567 August 26, 1997 Nierlich et al.
5688267 November 18, 1997 Panescu et al.
5690692 November 25, 1997 Fleming
5693042 December 2, 1997 Bioarski et al.
5695494 December 9, 1997 Becker
5696351 December 9, 1997 Benn et al.
5702386 December 30, 1997 Stern et al.
5702429 December 30, 1997 King
5707369 January 13, 1998 Vaitekunas et al.
5713896 February 3, 1998 Nardella
5720744 February 24, 1998 Eggleston et al.
5722975 March 3, 1998 Edwards et al.
5733281 March 31, 1998 Nardella
5749869 May 12, 1998 Lindenmeier et al.
5749871 May 12, 1998 Hood et al.
5755715 May 26, 1998 Stern
5766165 June 16, 1998 Gentelia et al.
5769847 June 23, 1998 Panescu
5772659 June 30, 1998 Becker et al.
5792138 August 11, 1998 Shipp
5797802 August 25, 1998 Nowak
5797902 August 25, 1998 Netherly
5814092 September 29, 1998 King
5817093 October 6, 1998 Williamson, IV et al.
5820568 October 13, 1998 Willis
5827271 October 27, 1998 Bussey et al.
5830212 November 3, 1998 Cartmell et al.
5836943 November 17, 1998 Miller, III
5836990 November 17, 1998 Li
5846236 December 8, 1998 Lindenmeier et al.
5868737 February 9, 1999 Taylor et al.
5868739 February 9, 1999 Lindenmeier et al.
5868740 February 9, 1999 LeVeen et al.
5871481 February 16, 1999 Kannenberg et al.
5897552 April 27, 1999 Edwards et al.
5908444 June 1, 1999 Azure
5913882 June 22, 1999 King
5921982 July 13, 1999 Lesh et al.
5925070 July 20, 1999 King et al.
5931836 August 3, 1999 Hatta et al.
5938690 August 17, 1999 Law et al.
5948007 September 7, 1999 Starkenbaum et al.
5951545 September 14, 1999 Schilling et al.
5951546 September 14, 1999 Lorentzen
5954686 September 21, 1999 Garito et al.
5954717 September 21, 1999 Behl et al.
5961344 October 5, 1999 Rosales et al.
5971980 October 26, 1999 Sherman
5976128 November 2, 1999 Schilling et al.
5983141 November 9, 1999 Sluijter et al.
6010499 January 4, 2000 Cobb
6014581 January 11, 2000 Whayne et al.
6033399 March 7, 2000 Gines
6044283 March 28, 2000 Fein et al.
6053910 April 25, 2000 Fleenor
6053912 April 25, 2000 Panescu et al.
6056745 May 2, 2000 Panescu et al.
6056746 May 2, 2000 Goble et al.
6063075 May 16, 2000 Mihori
6063078 May 16, 2000 Wittkampf
6068627 May 30, 2000 Orszulak et al.
6074386 June 13, 2000 Goble et al.
6080149 June 27, 2000 Huang et al.
6093186 July 25, 2000 Goble
RE36871 September 12, 2000 Epstein
6113591 September 5, 2000 Whayne et al.
6113596 September 5, 2000 Hooven
6123702 September 26, 2000 Swanson et al.
6132429 October 17, 2000 Baker
6142992 November 7, 2000 Cheng et al.
6162217 December 19, 2000 Kannenberg et al.
6203541 March 20, 2001 Keppel
6210403 April 3, 2001 Klicek
6228080 May 8, 2001 Gines
6228081 May 8, 2001 Goble
6231569 May 15, 2001 Bek
6235020 May 22, 2001 Cheng et al.
6238387 May 29, 2001 Miller, III
6238388 May 29, 2001 Ellman
6241725 June 5, 2001 Cosman
6245065 June 12, 2001 Panescu
6246912 June 12, 2001 Sluijter et al.
6251106 June 26, 2001 Becker et al.
6258085 July 10, 2001 Eggleston
6261285 July 17, 2001 Novak
6261286 July 17, 2001 Goble et al.
6273886 August 14, 2001 Edwards
6275786 August 14, 2001 Daners
6293941 September 25, 2001 Strul
6293942 September 25, 2001 Goble et al.
6306131 October 23, 2001 Hareyama et al.
6306134 October 23, 2001 Goble et al.
6309386 October 30, 2001 Bek
6337998 January 8, 2002 Behl et al.
6338657 January 15, 2002 Harper et al.
6358245 March 19, 2002 Edwards
6364877 April 2, 2002 Goble et al.
6383183 May 7, 2002 Sekino et al.
6398779 June 4, 2002 Buysse et al.
6398781 June 4, 2002 Goble et al.
6402741 June 11, 2002 Keppel et al.
6402743 June 11, 2002 Orszulak et al.
6416509 July 9, 2002 Goble et al.
6436096 August 20, 2002 Hareyama
6451015 September 17, 2002 Rittman, III et al.
6458121 October 1, 2002 Rosenstock
6464689 October 15, 2002 Qin
6464696 October 15, 2002 Oyama
6506189 January 14, 2003 Rittman, III et al.
6508815 January 21, 2003 Strul
6511476 January 28, 2003 Hareyama
6547786 April 15, 2003 Goble
6558376 May 6, 2003 Bishop
6562037 May 13, 2003 Paton
6565559 May 20, 2003 Eggleston
6573248 June 3, 2003 Ramasamy et al.
6575969 June 10, 2003 Rittman, III et al.
6582427 June 24, 2003 Goble et al.
6620157 September 16, 2003 Dabney et al.
6623423 September 23, 2003 Sakurai
6635057 October 21, 2003 Harano
6648883 November 18, 2003 Francischelli
6652514 November 25, 2003 Ellman
6663623 December 16, 2003 Oyama et al.
6663624 December 16, 2003 Edwards
6666860 December 23, 2003 Takahashi
6679875 January 20, 2004 Honda
6682527 January 27, 2004 Strul
6685700 February 3, 2004 Behl
6685701 February 3, 2004 Orszulak et al.
6692489 February 17, 2004 Heim
6712813 March 30, 2004 Ellman
6730080 May 4, 2004 Harano
6733495 May 11, 2004 Bek
6733498 May 11, 2004 Paton
6740079 May 25, 2004 Eggers
6740085 May 25, 2004 Hareyama
6783523 August 31, 2004 Qin
6790206 September 14, 2004 Panescu
6796981 September 28, 2004 Wham
6824539 November 30, 2004 Novak
6830569 December 14, 2004 Thompson
6843789 January 18, 2005 Goble
6849073 February 1, 2005 Hoey
6855141 February 15, 2005 Lovewell
6855142 February 15, 2005 Harano
6860881 March 1, 2005 Sturm
6864686 March 8, 2005 Novak
6875210 April 5, 2005 Refior
6893435 May 17, 2005 Goble
20010014804 August 16, 2001 Goble et al.
20010031962 October 18, 2001 Eggleston
20020035363 March 21, 2002 Edwards et al.
20020035364 March 21, 2002 Schoenman et al.
20020068932 June 6, 2002 Edwards
20020193787 December 19, 2002 Qin
20030004510 January 2, 2003 Wham et al.
20030060818 March 27, 2003 Kannenberg
20030078572 April 24, 2003 Pearson et al.
20030139741 July 24, 2003 Goble et al.
20030153908 August 14, 2003 Goble
20030163123 August 28, 2003 Goble
20030163124 August 28, 2003 Goble
20030171745 September 11, 2003 Francischelli
20030199863 October 23, 2003 Swanson
20040002745 January 1, 2004 Flemming
20040015163 January 22, 2004 Buysse et al.
20040019347 January 29, 2004 Sakurai
20040024395 February 5, 2004 Ellman
20040030328 February 12, 2004 Eggers
20040044339 March 4, 2004 Beller
20040049179 March 11, 2004 Francischelli
20040054365 March 18, 2004 Goble
20040059323 March 25, 2004 Sturm et al.
20040068304 April 8, 2004 Paton
20040082946 April 29, 2004 Malis
20040097912 May 20, 2004 Gonnering
20040097914 May 20, 2004 Pantera
20040097915 May 20, 2004 Refior
20040116919 June 17, 2004 Heim
20040133189 July 8, 2004 Sakurai
20040138653 July 15, 2004 Dabney et al.
20040138654 July 15, 2004 Goble
20040147918 July 29, 2004 Keppel
20040167508 August 26, 2004 Wham et al.
20040172016 September 2, 2004 Bek
20040193148 September 30, 2004 Wham et al.
20040230189 November 18, 2004 Keppel
20040243120 December 2, 2004 Orszulak et al.
20040260279 December 23, 2004 Goble
20050004564 January 6, 2005 Wham
20050021020 January 27, 2005 Blaha et al.
20050021022 January 27, 2005 Sturm et al.
20050101951 May 12, 2005 Wham
20050113818 May 26, 2005 Sartor
20050113819 May 26, 2005 Wham
20050149151 July 7, 2005 Orszulak
20050182398 August 18, 2005 Paterson
20050197659 September 8, 2005 Bahney
20050203504 September 15, 2005 Wham et al.
20060025760 February 2, 2006 Podhajsky
Foreign Patent Documents
179607 March 1905 DE
1099658 February 1961 DE
1139927 November 1962 DE
1149832 June 1963 DE
1439302 January 1969 DE
2439587 February 1975 DE
2455174 May 1975 DE
2407559 August 1975 DE
2602517 July 1976 DE
2504280 August 1976 DE
2540968 March 1977 DE
2820908 November 1978 DE
2803275 August 1979 DE
2823291 November 1979 DE
2946728 May 1981 DE
3143421 May 1982 DE
3045996 July 1982 DE
3120102 December 1982 DE
3510586 October 1986 DE
3604823 August 1987 DE
390937 April 1989 DE
3904558 August 1990 DE
3942998 July 1991 DE
19717411 November 1998 DE
246350 November 1987 EP
310431 April 1989 EP
325456 July 1989 EP
336742 October 1989 EP
390937 October 1990 EP
556705 August 1993 EP
608609 August 1994 EP
836868 April 1998 EP
878169 November 1998 EP
1293171 March 2003 EP
1275415 October 1961 FR
1347865 November 1963 FR
2313708 December 1976 FR
2502935 October 1982 FR
2517953 June 1983 FR
2573301 May 1986 FR
607850 September 1948 GB
855459 November 1960 GB
902775 August 1962 GB
2164473 March 1986 GB
2214430 September 1989 GB
166452 January 1965 SU
727201 April 1980 SU
WO92/06642 April 1992 WO
WO93/24066 December 1993 WO
WO94/24949 November 1994 WO
WO94/28809 December 1994 WO
WO95/09577 April 1995 WO
WO95/19148 July 1995 WO
WO96/02180 February 1996 WO
WO96/04860 February 1996 WO
WO96/08794 March 1996 WO
WO96/18349 June 1996 WO
WO96/29946 October 1996 WO
WO96/39914 December 1996 WO
WO97/06739 February 1997 WO
WO97/06740 February 1997 WO
WO97/06855 February 1997 WO
WO97/17029 May 1997 WO
WO02/11634 February 2002 WO
WO02/45589 June 2002 WO
WO02/47565 June 2002 WO
WO02/088128 July 2002 WO
WO03/092520 November 2003 WO
WO2004/028385 April 2004 WO
WO2004/098385 April 2004 WO
WO2005/046496 May 2005 WO
WO2005/048809 June 2005 WO
WO2005/050151 June 2005 WO
WO2005/060365 July 2005 WO
Other references
  • Alexander et al., “Magnetic Resonance Image-Directed Stereotactic Neurosurgery: Use of Image Fusion with Computerized Tomography to Enhance Spatial Accuracy” Journal Neurosurgery, 83; (1995) pp. 271-276.
  • Anderson et al., “A Numerical Study of Rapid Heating for High Temperature Radio Frequency Hyperthermia” International Journal of Bio-Medical Computing, 35 (1994) pp. 297-307.
  • Astrahan, “A Localized Current Field Hyperthermia System for Use with 192-Iridium Interstitial Implants” Medical Physics, 9 (3), May/Jun. 1982.
  • Bergdahl et al., “Studies on Coagulator and the Development of an Automatic computerized Bipolar Coagulation” Journal of Neurosurgery 75:1, (Jul. 1991) pp. 148-151.
  • Chicharo et al. “A Sliding Goertzel Algorith” Aug. 1996, pp. 283-297 Signal Processing, Elsevier Science Publishers B.V. Amsterdam, NL vol. 52 No. 3.
  • Cosman et al., “Methods of Making Nervous System Lesions” In William RH, Rengachary SS (eds): Neurosurgery, New York: McGraw-Hill, vol. 111, (1984), pp. 2490-2499.
  • Cosman et al. “Radiofrequency Lesion Generation and Its Effect on Tissue Impedance” Applied Neurophysiology 51: (1988) pp. 230-242.
  • Cosman et al., “Theoretical Aspects of Radiofrequency Lesions in the Dorsal Root Entry Zone” Neurosurgery 15:(1984) pp. 945-950.
  • Geddes et al., “The Measurement of Physiologic Events by Electrical Impedence” Am. J. MI, Jan. Mar. 1964, pp. 16-27.
  • Goldberg et al., “Tissue Ablation with Radiofrequency: Effect of Probe Size, Gauge, Duration, and Temperature on Lesion Volume” Acad Radio (1995) vol. 2, No. 5, pp. 399-404.
  • Ogden Goertzel Alternative to the Fourier Transform: Jun. 1993 pp. 485-487 Electronics World; Reed Business Publishing, Sutton, Surrey, BG vol. 99, No. 9, 1687.
  • Sugita et al., “Bipolar Coagulator with Automatic Thermocontrol” J. Neurosurg., vol. 41, Dec. 1944, pp. 777-779.
  • Vallfors et al., “Automatically Controlled Bipolar Electrosoagulation-‘COA-COMP’” Neurosurgical Review 7:2-3 (1984) pp. 187-190.
  • Wald et al., “Accidential Burns”, JAMA, Aug. 16, 1971, vol. 217, No. 7, pp. 916-921.
  • International Search Report PCT/US03/37110 dated Jul. 25, 2005.
  • International Search Report PCT/US03/37310 dated Aug. 13, 2004.
  • International Search Report EP 04009964 dated Jul. 13, 2004.
  • International Search Report EP 98300964.8 dated Dec. 4, 2000.
  • International Search Report EP 04015981.6 dated Sep. 29, 2004.
  • International Search Report EP 05014156.3 dated Dec. 28, 2005.
  • International Search Report EP 05021944.3 dated Jan. 18, 2006.
  • International Search Report EP 05022350.2 dated Jan. 18, 2006.
Patent History
Patent number: RE40388
Type: Grant
Filed: May 8, 2003
Date of Patent: Jun 17, 2008
Assignee: Covidien AG (Neuhausen am Rheinfall)
Inventor: David Lee Gines (Ft. Collins, CO)
Primary Examiner: Michael Peffley
Application Number: 10/434,019
Classifications
Current U.S. Class: Systems (606/34); With Switching Or Power Control (606/42)
International Classification: A61B 18/18 (20060101);